Back to GetFilings.com




1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549

FORM 10-K

ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 1996 Commission file number 1-496
-----------------------------------


HERCULES INCORPORATED

A DELAWARE CORPORATION
I.R.S. EMPLOYER IDENTIFICATION NO. 51-0023450
HERCULES PLAZA
1313 NORTH MARKET STREET
WILMINGTON, DELAWARE 19894-0001
TELEPHONE: 302-594-5000

Securities registered pursuant to Section 12(b) of the Act
(Each class is registered on the New York Stock Exchange, Inc.)

Title of each class
-------------------

Common Stock ($25/48 Stated Value)

6 1/2 % Convertible Subordinated Debentures due June 30, 1999

8% Convertible Subordinated Debentures due August 15, 2010


Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No ___

Indicate by check mark if disclosure of delinquent filers pursuant to
Item 405 of Regulation S-K is not contained herein, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]

As of February 24, 1997, registrant had outstanding 101,730,290 shares
of common stock, $25/48 stated value ("Common Stock"), which is registrant's
only class of common stock.

The aggregate market value of registrant's Common Stock held by
non-affiliates based on the closing price on February 24, 1997 was
approximately $4.9 billion.


DOCUMENTS INCORPORATED BY REFERENCE
(SPECIFIC PAGES INCORPORATED ARE IDENTIFIED UNDER THE APPLICABLE ITEM HEREIN.)

Portions of the registrant's definitive Proxy Statement dated March
14, 1997 (the "Proxy Statement") are incorporated by reference in Part lll of
this Report. Other documents incorporated by reference in this report are
listed in the Exhibit Index (see page 42).


2


PART I
(Dollars in millions, except per share)
ITEM 1. BUSINESS:
Hercules Incorporated ("Hercules" or the "company") is a diversified,
worldwide producer of chemicals and related products. The company was
incorporated in Delaware in 1912. During 1996, Hercules divested its Composite
Products Division (which produced graphite fiber) of its Corporate and other
segment. In 1995, Hercules divested its Aerospace segment (which produced
solid fuel systems) and the Electronics & Printing Division (which produced
photopolymer resins for printing and publishing applications) of its Food &
Functional Products segment. Accordingly, information related to the Aerospace
segment, Electronics & Printing Division, and Composite Products Division has
been omitted in this Form 10-K, except where relevant.

INDUSTRY SEGMENTS
Hercules operates, both domestically and throughout the world, in two
industry segments: Chemical Specialties and Food & Functional Products. The
financial information regarding Hercules' industry segments, which includes net
sales and profit from operations for each of the three years in the period
ended December 31, 1996 and identifiable assets as of December 31, 1996, 1995,
and 1994, is provided in Note 21 to the Consolidated Financial Statements.

Information regarding principal products produced and sold by each
industry segment and principal markets served by each segment is presented in
the columns so designated in the segment table presented below. These products
are sold directly to customers from plants and warehouses, as well as being
sold in some cases (particularly in markets outside the United States) to and
through distributors.



BUSINESS UNITS PRINCIPAL PRODUCTS PRIMARY MARKETS
- -------------- ------------------ ---------------
Chemical Specialties
- --------------------

Paper Technology Reactive sizes, rosin size, Writing and printing paper, tissues and
dispersed rosin sizes, wet- toweling, liquid packaging, kraft paper,
strength resins, wax emulsions, corrugated and linerboard packaging, and
defoamers, and retention aids. kraft specialties.

Fibers Polypropylene nonwoven fiber Disposable hygiene products, home
and polypropylene textile yarns. furnishings, and automotive.

Resins Rosin resins, hydrocarbon Adhesives for tapes, labels, carpet
resins, peroxides. backing, packaging, and sealants;
graphic arts, particularly inks and
toners; rubber, including plastic
compounds for wire and cable insulation;
the construction industry; and household
products.

Food & Functional Products
- --------------------------
Aqualon Carboxymethylcellulose, Paints and lacquers, adhesives, paper,
hydroxypropylcellulose, ethyl- personal care products and cosmetics,
cellulose, nitrocellulose, hydroxy- pharmaceuticals, food and beverages,
ethylcellulose, methylcellulose, inks, oil well drilling, rubber, and
and pentaerythritol. smokeless powder.

Food Gums Processed meats, jellies and jams, baked
goods, convenience foods, and beverages.


In general, Hercules does not produce against a backlog of firm orders;
production is geared primarily to the level of incoming orders and the
projections of future demand. Inventories of finished products, work in
process and raw materials are maintained to meet delivery requirements of
customers and Hercules' production schedules.







1
3

The businesses of each of the segments are not seasonal to any significant
extent.

RAW MATERIALS AND ENERGY
Raw materials and supplies are purchased from a variety of industry
sources, including agricultural, forestry, mining, petroleum and chemical
industries.

The important raw materials for the Chemical Specialties segment are
d-limonene, turpentine, crude tall oil, rosin, pine wood stumps, aromatic and
aliphatic resin formers, ketones, cumene, catalysts, alcohols, pure monomers,
toluene, clay, phenol, adipic acid, epichlorohydrin, fumaric acid, process
oils, stearic acid, diethylenetriamine, phosphorus trichloride, wax, casein,
starch, polypropylene resin, pigments, and antioxidants.

Raw materials important to the Food & Functional Products segment are
acetaldehyde, fatty acids, chemical cotton, woodpulp, ethyl chloride, alcohols,
chlorine, ethylene oxide, propylene oxide, monochloroacetic acid, methyl
chloride, caustic, inorganic acids, fruit and floral extracts, guar splits,
seaweed, terpenes, and citrus peel.

Major requirements for key raw materials and fuels are typically
purchased pursuant to multi-year contracts. Hercules is not dependent on any
one supplier for a material amount of its raw material or fuel requirements,
but certain important raw materials are obtained from sole-source or a few
major suppliers.

While temporary shortages of raw materials and fuels may occur
occasionally, these items are currently readily available. However, their
continuing availability and price are subject to domestic and world market and
political conditions as well as to the direct or indirect effect of United
States Government regulations. The impact of any future raw material and energy
shortages on Hercules' business as a whole or in specific world areas cannot be
accurately predicted. Operations and products may, at times, be adversely
affected by legislation, shortages or international or domestic events.

COMPETITION
Hercules encounters substantial competition in each of its two
industry segments. This competition, from other manufacturers of the same
products and from manufacturers of different products designed for the same
uses, is expected to continue in both the United States and markets outside the
United States. Some of Hercules' competitors, such as companies engaged in
petroleum operations, have more direct access to raw materials, and some have
greater financial resources than Hercules.

The number of Hercules' principal competitors varies from product to
product. It is not practicable to estimate the number of all competitors
because of the large variety of Hercules' products, the markets served and the
worldwide business interests of Hercules.

PATENTS AND TRADEMARKS
Patents covering a variety of products and processes have been issued
to Hercules and its assignees. In addition, Hercules is licensed under certain
other patents covering the products and processes. Taken as a whole, the rights
of Hercules under these patents and licenses, which expire from time to time,
are considered by Hercules to constitute a valuable asset. However, Hercules
does not consider any single patent or license, or any group thereof related to
a specific product or process, to be of material importance to its business as
a whole.

Hercules also has registered trademarks for a number of its products.
Some of the more significant trademarks include: AQUAPEL(R) sizing agent,
HERCON(R) sizing emulsions, KYMENE(R) resin, REGALREZ(R) resin, HERCULON(R)
olefin fiber, SLENDID(R) fat replacer, NATROSOL(R) hydroxyethylcellulose,
CULMINAL(R) methylcellulose, KLUCEL(R) hydroxypropylcellulose, NATROSOL FPS(R)
water-soluble polymer suspension, and PRECIS(R) sizing agent.








2
4

(Dollars in Millions, except per share)
RESEARCH AND DEVELOPMENT
Research and development, which is directed toward the discovery and
development of new products and processes, the improvement and refinement of
existing products and processes and development of new applications for
existing products, is primarily company-sponsored. Hercules spent $56 on
research activities during 1996, as compared to $59 in 1995 and $65 in 1994.
During the three-year period, research and development expenditures for the
Chemical Specialties and Food & Functional Products segments were between 1.8%
and 2.3% of sales.

ENVIRONMENTAL MATTERS
Hercules believes that it is in compliance in all material respects
with applicable federal, state, and local environmental laws and regulations.
Expenditures relating to environmental cleanup costs have not and are not
expected to materially affect capital expenditures or competitive position.
Additional information regarding environmental matters is provided in Note 20
to the Consolidated Financial Statements.

EMPLOYEES
As of December 31, 1996, Hercules had 7,114 employees worldwide.
Approximately 4,334 were located in the United States, and of these employees
about 32% were represented by various local or national unions.

INTERNATIONAL OPERATIONS
Information on net sales, profit from operations, identifiable assets
by geographic areas, and the amount of export sales, for each of the last three
years appears in Note 21 to the Consolidated Financial Statements. Hercules'
operations outside the United States are subject to the usual risks and
limitations related to investments in foreign countries, such as fluctuations
in currency values, exchange control regulations, wage and price controls,
employment regulations, effects of foreign investment laws, governmental
instability (including expropriation or confiscation of assets) and other
potentially detrimental domestic and foreign governmental policies affecting
United States companies doing business abroad.

OTHER MATTERS
In late February and March of 1997, the company announced several
organizational changes in executive leadership. These included a new president,
chief operating officer, and member of the Board of Directors; a new senior
vice president, International; a new vice president and general manager,
Fibers; a new senior vice president, Manufacturing; and a new president,
Hercules Europe. In conjuction with these changes, management has adopted
alternative competitive strategies designed to strengthen current businesses.
This action will result in a rationalization of assets and a reduction in
force, primarily at the company's operating facilities, which together with
other miscellaneous write-downs and accruals, will result in a first-quarter
after tax charge to earnings ranging from approximately $130 million to $170
million.


ITEM 2. PROPERTIES:
The company's corporate headquarters and major research center are
located in Wilmington, Delaware. Information as to Hercules' principal
manufacturing facilities and the industry segment served by each is presented
below.

All principal properties are owned by Hercules except for the
company's corporate headquarters, which is leased to the company.

The following are Hercules' major worldwide plants:
Chemical Specialties - Aberdeen, Scotland; Beringen, Belgium;
Brunswick, Georgia; Burlington, Ontario, Canada; Busnago, Italy;
Chicopee, Massachusetts; Franklin, Virginia; Gibbstown, New Jersey;
Hattiesburg, Mississippi; Iberville, Quebec, Canada; Jefferson,
Pennsylvania; Kalamazoo, Michigan; Kim Cheon, Korea; Lilla Edet,
Sweden; Mexico City, Mexico; Middelburg, the Netherlands; Milwaukee,
Wisconsin; Nantou, Taiwan; Oxford, Georgia; Pandaan, Indonesia;
Paulinia, Brazil; Pendlebury, England; Portland, Oregon; St.-Jean,
Quebec, Canada; Sandarne, Sweden; Savannah, Georgia; Sobernheim,
Germany; Tampere, Finland; Tampico, Mexico; Tarragona, Spain; Traun,
Austria; Uruapan, Mexico; Voreppe, France; Zwijndrecht, the
Netherlands. Food & Functional Products - Alizay, France; Doel,
Belgium; Grossenbrode, Germany; Hopewell, Virginia; Kenedy, Texas;
Lille Skensved, Denmark; Louisiana, Missouri; Parlin, New Jersey;
Zwijndrecht, the Netherlands.

Hercules plants and facilities, which are continually added to and
modernized, are generally considered to be in good condition and adequate for
business operations. From time to time Hercules discontinues operations at, or
disposes of, facilities that have for one reason or another become unsuitable.








3
5


ITEM 3. LEGAL PROCEEDINGS:
For discussion of legal proceedings see Note 20 to the Hercules
Financial Statements.

In September 1993, Hercules and the U.S. Environmental Protection
Agency (EPA) Region 1 reached an agreement in principle in settlement of EPA's
claims that Hercules violated its wastewater permit with the City of Chicopee
and the Federal pretreatment standard for industrial users of publicly owned
treatment works at its Chicopee, Massachusetts, facility. Hercules signed a
consent Decree, which was entered by the court on December 15, 1994, based on
this agreement, requiring supplemental environmental projects (at a cost of
approximately $375,000), compliance with permit limits in the future, and
$250,000 in fines. Hercules has paid the $250,000 fine and is currently in the
process of performing the supplemental environmental projects, which are
expected to be completed in 1997.

Hercules received a letter from the New Jersey Department of
Environmental Protection (the "Department") dated March 9, 1995, which stated
that the Department was considering an enforcement action against Hercules for
alleged noncompliance with the terms of a 1993 Administrative Consent Order
("ACO") at its Kenvil, New Jersey, facility and other alleged violations. The
ACO covered alleged violations of the Air Pollution Control Act. The other
alleged violations were under the Spill Compensation and Control Act, the New
Jersey Water Pollution Control Act, and the New Jersey Safe Drinking Water Act.
On March 4, 1997 Hercules received from the Department a formal demand for
payment of stipulated penalties under the ACO as well as for civil penalties
for the other alleged violations. Hercules is evaluating the demand and is
discussing a possible resolution with the Department at a value which will not
have a material impact on the company's financial condition.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS:
No matter was submitted to a vote of security holders during the
fourth quarter of 1996, through the solicitations of proxies or otherwise.
















4
6
EXECUTIVE OFFICERS OF THE REGISTRANT:

The name, age and current position of each executive officer (as
defined by Securities and Exchange Commission rules) of the company as of
February 24, 1997, are listed below. Each of the officers, except for Herbert
K. Pattberg*, Vikram Jog, Richard G. Dahlen and John M. Bondur, have served in
one or more executive capacities with the company and/or its affiliates during
the past five years. Herbert Pattberg was employed by Henkel KgaA for 22
years, most recently as group vice president, Oleochemicals. Mr. Pattberg
joined Hercules in 1993 in his present position of president, S.A. Hercules
Europe N.V., Brussels, Belgium. Vikram Jog has been with Hercules since 1992,
as director, Corporate Reporting, director, Corporate Analysis, Controller, and
now his current position as vice president and controller. Prior to joining
Hercules, Mr. Jog was employed at Price Waterhouse LLP and Coopers & Lybrand
L.L.P. Richard Dahlen was employed by Monsanto Company for 30 years, holding
positions in its Law Department. He joined Hercules in 1996 as vice president
and general counsel. John Bondur joined Hercules in January 1997 as vice
president, Human Resources. Prior to joining Hercules, Mr. Bondur was senior
vice president, Human Resources and Communications, for Witco Corporation.
There are no family relationships among executive officers.




NAME AGE CURRENT POSITION

R. Keith Elliott 54 Chairman and Chief Executive Officer
Vincent J. Corbo 53 President and Chief Operating Officer
C. Doyle Miller 56 Senior Vice President
George MacKenzie 47 Senior Vice President and Chief Financial Officer
Dominick W. DiDonna 48 Senior Vice President and General Manager
Richard G. Dahlen 57 Vice President and General Counsel
Vikram Jog 40 Vice President and Controller
Jan M. King 47 Vice President and Treasurer
Israel J. Floyd 50 Secretary and Assistant General Counsel
James D. Beach 61 Vice President, Operations Support
John M. Bondur 53 Vice President, Human Resources
James R. Rapp 58 Vice President, Corporate Relations
Harry J. Tucci 56 Vice President, Corporate Development
Herbert K. Pattberg 53 President, Hercules Europe






* Herbert K. Pattberg has decided to leave Hercules, effective March 7, 1997.





















5
7
PART II


ITEM 5. MARKET FOR THE REGISTRANT'S COMMON STOCK AND RELATED STOCKHOLDER
MATTERS:

Hercules Incorporated common stock is listed on the New York Stock Exchange
(ticker symbol HPC), The Stock Exchange, London, and the Swiss Stock Exchange.
It is also traded on the Philadelphia, Midwest, and Pacific Stock Exchanges.

On December 8, 1994, the company announced a three-for-one split of its
common stock effected in the form of a 200% tax-free stock dividend distributed
on January 30, 1995, to shareholders of record as of January 9, 1995. The
information presented below reflects the three-for-one stock split.

The approximate number of holders of record of common stock ($25/48 stated
value) as of January 31, 1997, was 20,215



Period High Low
------ ---- ---

1995
First Quarter . . . . . . . . . . . . . . . . . . . . 49 1/8 38 1/4
Second Quarter . . . . . . . . . . . . . . . . . . . . 53 5/8 46
Third Quarter . . . . . . . . . . . . . . . . . . . . 62 1/4 48 1/4
Fourth Quarter . . . . . . . . . . . . . . . . . . . . 59 5/8 51 1/2
1996
First Quarter . . . . . . . . . . . . . . . . . . . . 66 1/4 54
Second Quarter . . . . . . . . . . . . . . . . . . . . 62 7/8 53 3/8
Third Quarter . . . . . . . . . . . . . . . . . . . . 56 3/8 47 1/2
Fourth Quarter . . . . . . . . . . . . . . . . . . . . 56 1/4 42 3/4



On December 31, 1996, the closing price of the common stock was 43 1/4.

The company has paid quarterly cash dividends as follows:



1st Quarter 2nd Quarter 3rd Quarter 4th Quarter
----------- ----------- ----------- -----------

1995 . . . . . . . . . . . . . . . $0.21 $0.21 $0.21 $0.21
1996 . . . . . . . . . . . . . . . $0.23 $0.23 $0.23 $0.23





















6
8
ITEM 6. SELECTED FINANCIAL DATA:
A summary of selected financial data for Hercules for the years and year
ends specified is set forth in the table below.


(Dollars and shares in millions, except per share)


- ---------------------------------------------------------------------------------------------------------------
FOR THE YEAR 1996 1995 1994 1993 1992
- ---------------------------------------------------------------------------------------------------------------

Net sales $2,060 $2,427 $2,821 $2,773 $2,865
Profit from operations 441 363 419 308 244
Income before extraordinary item and
effect of changes in accounting principles 325 333 274 208 168
Net income (loss) 325 333 274 (33) 168
Dividends 95 95 89 95 101
Per share of common stock
Earnings before extraordinary item and
effect of changes in accounting principles 3.04 2.93 2.29 1.62 1.23
Earnings (loss) 3.04 2.93 2.29 (.26) 1.23
Dividends .92 .84 .75 .75 .75
Total assets 2,386 2,493 2,941 3,162 3,228
Long-term debt 345 298 307 317 431



ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS:

This discussion should be read in connection with the information contained
in the Consolidated Financial Statements and Notes thereto.

The table below reflects the results of operations on both a consolidated and
segment basis, excluding divested businesses. (See Note 19.) The amounts
exclude the results of operations of the Aerospace segment, divested in March
1995; the Electronics & Printing Division of the Food & Functional Products
segment, divested in December 1995; and the Composite Products and Packaging
Films Divisions of the Corporate and other segment, divested in June 1996 and
April 1994, respectively. The table should make it easier to compare
year-over-year operating results. Accordingly, the discussion that follows
speaks to the comparisons in the table through profit from operations.




(Dollars in millions) (Unaudited)
1996 1995 1994
---------------------------------------

Net sales $ 2,012 $ 2,140 $ 1,964

Cost of sales 1,279 1,387 1,296
Selling, general, and administrative expenses 258 326 278
Research and development 56 55 52
Other operating expenses (income), net (14) 36 28
---------------------------------------
Profit from operations $ 433 $ 336 $ 310
=======================================
Net sales by industry segment
Chemical Specialties $1,085 $ 1,154 $ 1,081
Food & Functional Products 923 980 878
Corporate and other 4 6 5
---------------------------------------
Total $2,012 $ 2,140 $ 1,964
=======================================
Profit from operations by industry segment
Chemical Specialties $ 205 $ 211 $ 197
Food & Functional Products 217 171 137
Corporate and other 11 (46) (24)
---------------------------------------
Total $ 433 $ 336 $ 310
=======================================






7
9

Net sales declined 6%, or $128 million, in 1996. Lower volume and weaker
foreign currencies relative to the dollar account for most of the sales
decline. In 1995, sales increased 9%, or $176 million. Higher selling prices
and favorable foreign currencies accounted for much of the improvement.

Profit from operations: Despite lower sales, profit from operations increased
29%, or $97 million, in 1996 due to three major reasons. (i) Revisions to
long-term incentive compensation plans in 1995, outlined in the following
paragraph, reduced selling, general, and administrative expenses (SG&A) in 1996
by $68 million. In addition, 1995 SG&A charges were abnormally high and
included early vesting of the 1993 and 1994 long-term incentive programs and
the grant of stock awards to all Hercules employees. (See Note 8.) (ii)
Other operating expenses (income), net (see Note 12), were $50 million lower in
1996. Environmental remediation costs at the Jacksonville, Arkansas, site were
lower in 1996 versus 1995 and no additional sites were identified requiring
significant environmental expenditures. Additionally, 1996 includes $13
million of probable recoveries related to environmental remediation. (iii)
Manufacturing cost improvements increased overall gross margins to 36% from 35%
and partially offset the volume-driven decline in gross profit dollars.

In 1995, profit from operations increased 8%, or $26 million. Higher selling
prices and manufacturing cost improvements led to increased gross profit of $85
million, and gross profit margin increased to 35% from 34%. SG&A expenses
increased $48 million, primarily from the early vesting of the 1993 and 1994
long-term incentive compensation programs and the grant of stock awards to all
Hercules employees. During 1995, long-term incentive compensation programs
were revised. Awards of restricted stock and performance shares were replaced
by stock options, performance-accelerated stock options, and cash-value awards
payable in shares of Hercules stock. Other operating expenses (income), net,
increased $8 million. Higher environmental costs, particularly those
associated with the Jacksonville site, accounted for most of the increased
expense.

Chemical Specialties: Net sales declined 6%, or $69 million, in 1996.
Increased competition from a new competitor and a competitive technology, and
negative customer reaction to previous pricing strategies, reduced demand and
lowered prices for polypropylene nonwoven fiber. Additionally, lower demand in
the construction, adhesives, and tape markets and unfavorable rates of exchange
reduced Resins revenues. Partially offsetting these reductions were higher
revenues in Paper Technology related to increased volume of wet-strength and
alkaline-size products in Europe and new business in Asia and South America.

Profit from operations declined 3%, or $6 million, in 1996. Lower revenue and
higher raw material costs were partially offset by manufacturing cost
improvements and lower costs for employee incentive compensation.

In 1995, net sales increased 7%, or $73 million. Improved pricing, stronger
foreign currencies, and increased volume of higher value wet-strength products
and polypropylene nonwoven fiber more than offset market softness and lower
demand for Resins and Paper Technology products. Profit from operations
increased 7%, or $14 million, in 1995. Margins were unchanged as gains from
higher revenues and manufacturing cost improvements were offset by higher raw
material costs, lower production volume, and increased SG&A costs associated
with higher incentive compensation.

Food & Functional Products: Net sales declined 6%, or $57 million, in 1996.
Lower overall volume in the construction, oilfield, and food markets, coupled
with unfavorable rates of exchange, account for much of the decline. These
declines were softened by improved pricing, particularly in Aqualon.

Profit from operations increased 27%, or $46 million, in 1996. Improved
pricing, manufacturing cost improvements, and lower employee incentive
compensation costs offset the volume decline and increases in raw material
costs.

In 1995, net sales increased 12%, or $102 million. Higher selling prices and
stronger foreign currencies contributed to growth in both Aqualon and Food
Gums. Aqualon volumes were marginally higher; however, lower demand in food
markets in the second half of the year reduced overall volume. Profit from
operations increased 25%, or $34 million, in 1995. Higher revenues, coupled
with manufacturing cost





8
10
improvements, were partially offset by higher raw material costs and lower
yields, particularly in Food Gums. Higher SG&A costs associated with higher
incentive compensation also reduced operating profit.

Looking ahead, Hercules anticipates the markets it serves to strengthen in
1997. This, along with programs to improve its competitive position, should
result in volume improvements. However, because the company supplies
relatively mature industries, high growth rates will be difficult to achieve.
The significant strengthening of the dollar against European currencies through
1996 and early 1997 adds an additional challenge. Also, a fire in the
company's pectin production facility in late January will cost it four to six
weeks of high-value production. Manufacturing cost improvements will continue
to be a critical element of success, particularly if raw material costs
escalate. The company anticipates that 1997 will be a challenging year;
however, overall financial performance is expected to be ahead of 1996.*

Corporate and other: Operating profit increased $57 million in 1996 from lower
environmental remediation expenses and recognition of probable recoveries for
environmental remediation.

In 1995, operating losses increased $22 million from higher environmental
costs.

Equity in income of affiliated companies increased $12 million. The
improvement reflects a full year of equity earnings from Hercules' 30% stake in
Alliant Techsystems, acquired in March 1995 in conjunction with the sale of the
Aerospace segment. Improved earnings from Tastemaker, a 50%-owned flavors
joint venture, also added to the improvement. In 1995, income improved $15
million, reflecting the newly acquired interest in Alliant Techsystems, along
with improved Tastemaker earnings.

Interest and debt expense increased $7 million from higher average debt over
the period. In 1995, interest and debt expense remained relatively flat as the
effect of lower average debt was offset by lower capitalized interest related
to reduced capital spending.

Other income (expense), net (see Note 14), decreased $103 million in 1996 and
increased $137 million in 1995. The increase in 1995 and subsequent decrease in
1996 primarily relates to gains on the sale of the Aerospace segment and
Electronics & Printing Division in 1995.

The provision for income taxes reflects effective tax rates of 33% in 1996, 34%
in 1995, and 33% in 1994. The 1996 rate was favorably affected by the use of
tax loss carryforwards. The 1995 rate was favorably affected by the increased
use of foreign tax credits and a state income tax settlement related to a prior
year sale of an investment. The 1994 rate was favorably affected by research
and experimentation tax credits. (See Note 15.)

FINANCIAL CONDITION
Liquidity and financial resources: Net cash flow from operations was $225
million in 1996, $328 million in 1995, and $298 million in 1994. The decrease
in 1996 primarily relates to higher tax payments and increased working capital
requirements. The higher tax payments in 1996 relate to the divestiture of the
Electronics & Printing Division and settlement of prior years' federal income
tax audits. The increase in 1995 primarily related to reduced working capital
requirements and lower income tax payments. Total cash flow was favorably
affected by proceeds from asset disposals of $196 million in 1996, $376 million
in 1995, and $202 million in 1994.

In the three-year period ended December 31, 1996, the company satisfied its
cash requirements for capital expenditures, other investing activities, and
dividends entirely from operating cash flows.




* This paragraph contains forward-looking statements and is included here to
provide safe harbor under the Private Securities Litigation Reform Act of
1995.





9
11
In addition to internally generated cash, various credit sources are available
to the company. These include short-term lines of credit, of which $113
million was available at December 31, 1996, and revolving credit agreements
with several banks providing $380 million, of which $65 million was available
at December 31, 1996. In addition, the company has a shelf registration in the
amount of $50 million available, subject to market conditions. In February
1997, the Board authorized actions to increase revolving credit agreements to
$700 million and increase the amount available under shelf registration to $500
million.

Capital expenditures remained relatively flat at $120 million in 1996, while
declining from $164 million in 1994. This decrease relates primarily to the
completion in 1994 of the methylcellulose facility in Doel, Belgium.

During 1995, the company increased the deductible for property and business
interruption insurance to $50 million. This change, which lowers premium
costs, was prompted by the divestiture of the Aerospace segment and the
favorable loss experience in continuing businesses.

Commitments and capital structure: Total capitalization (stockholders' equity
plus debt) remained relatively flat at $1.5 billion at December 31, 1996.
Stockholders' equity declined $195 million as share repurchases continued,
while total debt increased $153 million. As a result, total debt as a
percentage of capitalization increased to 43% from 32%. As management
continues to focus on an interest coverage rate of 10 to 12 times, this ratio
will likely increase over time. Interest coverage declined to 12 times in 1996
from 15 times in 1995.

In February 1997, the company announced Board approval for the continuation of
the stock-repurchase program and authorized the repurchase of up to 10 million
additional shares of Hercules stock.

Fluctuations in interest and foreign currency exchange rates affect the
company's financial position and results of operations. The company uses
several strategies to actively hedge interest rate and foreign currency
exposure and minimize the effect of such fluctuations on reported earnings.
(See "Foreign Currency Translation" and "Financial Instruments and Hedging" in
the Summary of Significant Accounting Policies and Notes 14 and 17.) There are
presently no significant restrictions on the remittance of funds generated by
the company's operations outside the United States.

Hercules has been identified by U.S. federal and state authorities as a
"potentially responsible party" for environmental cleanup at numerous sites.
The estimated range of reasonably possible costs for remediation is between $70
million and $246 million. The company does not anticipate that its financial
condition will be materially affected by environmental remediation costs in
excess of amounts accrued, although quarterly or annual operating results could
be materially affected. (See Note 20.)

Environmental remediation expenses are funded from internal sources of cash.
Such expenses are not expected to have a significant effect on the company's
ongoing liquidity. Environmental cleanup costs, including capital expenditures
for ongoing operations, are a normal, recurring part of operations and are not
significant in relation to total operating costs or cash flows.

A quarterly dividend has been paid without interruption since 1913, the
company's first year of operation. The annual dividend of $.92 per share
during 1996 represents a total payout for the year of $95 million.
Additionally, in December 1996, the company announced a 9% quarterly dividend
increase to $.25 per share, payable March 25, 1997, to shareholders of record
on March 7, 1997.

During 1996, 29% of capital expenditures were related to increased production
capacity, compared with 23% in 1995 and 43% in 1994. The remainder mostly
relates to cost-savings projects, regulatory requirements, and research
facilities. Capital expenditures are expected to approximate $152 million
during 1997. This amount includes funds for continuing or completing existing
projects related to cost savings, a hydrocarbon resins expansion in Middelburg,
the Netherlands, and a carrageenan plant in Cebu, the Philippines.








10
12

In February 1997, the company announced the signing of an agreement by
Tastemaker, the 50%-owned flavors joint venture, to divest its operating assets
to Roche, the Swiss parent company of Givaudan-Roure. The transaction is
expected to result in a financial gain. In conjunction with the transaction,
it is management's intention to increase leverage so that the net cash value of
the transaction to Hercules approximates $550 million. Currently, it is
management's intention to use the cash to repurchase Hercules shares. The
transaction is expected to close during the first half of 1997, subject to
regulatory and other customary approvals. (See Note 18.)


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA:

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND
REQUIRED SUPPLEMENTARY DATA
HERCULES INCORPORATED



Page
----

CONSOLIDATED FINANCIAL STATEMENTS
Report of Independent Accountants . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Consolidated Statement of Income for the Years Ended December 31, 1996, 1995,
1994 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Consolidated Balance Sheet as of December 31, 1996 and 1995 . . . . . . . . . . . . . . . 14
Consolidated Statement of Cash Flow for the Years Ended December 31, 1996,
1995, and 1994 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Consolidated Statement of Stockholders' Equity for the Years Ended December 31,
1996, 1995, and 1994 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . 20-36

SUPPLEMENTARY DATA
Summary of Quarterly Results (Unaudited) . . . . . . . . . . . . . . . . . . . . . . . . . 37
Subsidiaries of Registrant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38






















11
13
REPORT OF INDEPENDENT ACCOUNTANTS


To the Shareholders and the Board of Directors of
Hercules Incorporated
Wilmington, Delaware

We have audited the accompanying consolidated balance sheets of Hercules
Incorporated and subsidiary companies as of December 31, 1996 and 1995, and the
related consolidated statements of income, stockholders' equity, and cash flow
for each of the three years in the period ended December 31, 1996. These
financial statements are the responsibility of the company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.

We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe our audits provide a reasonable basis for
our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of Hercules
Incorporated and subsidiary companies as of December 31, 1996 and 1995, and the
consolidated results of their operations and cash flow for each of the three
years in the period ended December 31, 1996, in conformity with generally
accepted accounting principles.



2400 Eleven Penn Center
Philadelphia, Pennsylvania 19103
February 7, 1997


















12
14
Hercules Incorporated
Consolidated Statement of Income
(Dollars in millions, except per share)



Year Ended December 31,
- -------------------------------------------------------------------------------------------------------------
1996 1995 1994
----------------------------------------------

Net sales $ 2,060 $2,427 $2,821
----------------------------------------------

Cost of sales 1,320 1,591 1,924
Selling, general, and administrative expenses 262 367 374
Research and development 56 59 65
Other operating expenses (income), net (Note 12) (19) 47 39
----------------------------------------------

Profit from operations 441 363 419

Equity in income of affiliated companies 53 41 26
Interest and debt expense (Note 13) 35 28 28
Other income (expense), net (Note 14) 26 129 (9)
----------------------------------------------

Income before income taxes 485 505 408
Provision for income taxes (Note 15) 160 172 134
----------------------------------------------

Net income $ 325 $ 333 $ 274
==============================================

Earnings per share $ 3.04 $ 2.93 $ 2.29
==============================================




The accompanying accounting policies and notes are an integral part of the
consolidated financial statements.

















13
15
Hercules Incorporated
Consolidated Balance Sheet (Dollars in millions)



December 31,
- --------------------------------------------------------------------------------------------------------------
1996 1995
--------------------------

ASSETS

Current assets
Cash and cash equivalents $ 30 $ 73
Accounts receivable, net (Note 1) 394 426
Inventories (Note 2) 279 308
Deferred income taxes (Note 15) 36 60
--------------------------
Total current assets 739 867

Property, plant, and equipment, net (Note 9) 865 1,000
Investments (Note 3) 364 344
Prepaid pension (Note 10) 193 175
Deferred charges and other assets 225 107
--------------------------
Total assets $ 2,386 $ 2,493
==========================

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities
Accounts payable $ 140 $ 117
Short-term debt (Note 4) 313 207
Accrued expenses (Note 9) 241 363
--------------------------
Total current liabilities 694 687

Long-term debt (Note 5) 345 298
Deferred income taxes (Note 15) 129 95
Other postretirement benefits (Note 11) 154 165
Deferred credits and other liabilities 177 166

Stockholders' equity
Series preferred stock (Note 6) -- --
Common stock (Note 7)
(shares issued: 1996--152,269,076; 1995--151,663,465) 79 79
Additional paid-in capital 493 472
Foreign currency translation adjustment 45 75
Retained earnings 1,942 1,712
--------------------------
2,559 2,338
Reacquired stock, at cost (shares: 1996--50,866,562; 1995--43,176,841) 1,672 1,256
--------------------------
Total stockholders' equity 887 1,082
--------------------------

Total liabilities and stockholders' equity $ 2,386 $ 2,493
==========================



The accompanying accounting policies and notes are an integral part of the
consolidated financial statements.










14
16
Hercules Incorporated
Consolidated Statement of Cash Flow (Dollars in millions)




Year Ended December 31,
- ----------------------------------------------------------------------------------------------------------------------
1996 1995 1994
----------------------------------------

CASH FLOW FROM OPERATING ACTIVITIES:
Net income $ 325 $ 333 $ 274
Adjustments to reconcile net income to net cash provided from operations:
Depreciation 106 133 148
Contract deferrals and provisions -- (7) (48)
Nonoperating gain on disposals (22) (132) (14)
Other (14) 70 58
Accruals and deferrals of cash receipts and payments:
Affiliates' earnings in excess of dividends received (25) (19) (6)
Accounts receivable 6 45 (18)
Inventories (17) 27 36
Accounts payable and accrued expenses (77) (92) (78)
Noncurrent assets and liabilities (57) (30) (54)
----------------------------------------
Net cash provided from operations 225 328 298
----------------------------------------

CASH FLOW FROM INVESTING ACTIVITIES:
Capital expenditures (120) (117) (164)
Proceeds of investment and fixed asset disposals 196 376 202
Payments for businesses acquired, net of cash acquired -- (6) (2)
Other (6) 13 5
----------------------------------------
Net cash provided from investing activities 70 266 41
----------------------------------------

CASH FLOW FROM FINANCING ACTIVITIES:
Long-term debt proceeds 75 97 79
Long-term debt repayments (27) (78) (138)
Change in short-term debt 112 14 98
Common stock issued 15 15 9
Common stock reacquired (417) (584) (342)
Dividends paid (95) (95) (89)
----------------------------------------
Net cash used for financing activities (337) (631) (383)
Effect of exchange rate changes on cash (1) (2) 1
----------------------------------------
Net decrease in cash and cash equivalents (43) (39) (43)
Cash and cash equivalents at beginning of year 73 112 155
----------------------------------------
Cash and cash equivalents at end of year $ 30 $ 73 $ 112
========================================

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the year for:
Interest (net of amount capitalized) $ 30 $ 30 $ 31
Income taxes paid, net 190 134 194
Noncash investing and financing activities:
Conversion of notes and debentures 1 28 31
Incentive plan stock issuances 14 58 41
Accounts payable for common stock acquisitions 8 1 8
Investment in unconsolidated affiliates 1 174 --
Accounts receivable from sale of investment/asset disposals 9 -- --
----------------------------------------




The accompanying accounting policies and notes are an integral part of the
consolidated financial statements.







15
17
Hercules Incorporated
Consolidated Statement of Stockholders' Equity (Dollars in millions)




Common Paid-In Translation Retained Reacquired
Stock Capital Adjustment Earnings Stock
- ---------------------------------------------------------------------------------------------------------------------------------

Balances at January 1, 1994 $31 $454 $30 $1,955 $1,101
(Common shares: issued 59,899,295; reacquired, 19,062,295)

Net Income -- -- -- 274 --
Cash dividends, $.75 per common share -- -- -- (89) --
Foreign currency translation adjustment -- -- 19 -- --
Purchase of common stock, 2,981,500 shares -- -- -- -- 328
Issuance of common stock:
Incentive plans, net, 317,262 shares including
217,106 from reacquired stock -- 4 -- -- (14)
Conversion of notes and debentures, 705,702 shares 1 31 -- -- --
Retirement of reacquired stock, 11,000,000 shares (6) (94) -- (614) (714)
Three-for-one common stock split effected
in the form of a stock dividend: issued
99,410,306 shares; 21,653,378 treasury shares 52 -- -- (52) --

- ----------------------------------------------------------------------------------------------------------------------------------
Balances at December 31, 1994 $78 $395 $49 $1,474 $701
(Common shares: issued 149,115,459; reacquired, 32,480,067)

Net income -- -- -- 333 --
Cash dividends, $.84 per common share -- -- -- (95) --
Foreign currency translation adjustment -- -- 26 -- --
Purchase of common stock, 11,546,399 shares -- -- -- -- 577
Issuance of common stock:
Incentive plans, net, 1,476,805 shares including
849,625 from reacquired stock -- 50 -- -- (22)
Conversion of notes and debentures, 1,920,826 shares 1 27 -- -- --

- ---------------------------------------------------------------------------------------------------------------------------------
Balances at December 31, 1995 $79 $472 $75 $1,712 $1,256
(Common shares: issued 151,663,465; reacquired, 43,176,841)

Net Income -- -- -- 325 --
Cash dividends, $.92 per common share -- -- -- (95) --
Foreign currency translation adjustment -- -- (30) -- --
Purchase of common stock, 7,970,784 shares -- -- -- -- 425
Issuance of common stock:
Incentive plans, net, 844,751 shares including
281,063 from reacquired stock -- 20 -- -- (9)
Conversion of notes and debentures, 41,923 shares -- 1 -- -- --

- ---------------------------------------------------------------------------------------------------------------------------------
Balances at December 31, 1996 $79 $493 $45 $1,942 $1,672
(Common shares: issued 152,269,076; reacquired, 50,866,562)




The accompanying accounting policies and notes are an integral part of the
consolidated financial statements.






16
18
HERCULES INCORPORATED
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of Hercules
Incorporated and all wholly owned subsidiaries. Investments in affiliated
companies with a 20% or greater ownership interest are accounted for on an
equity basis and, accordingly, consolidated income includes Hercules' share of
their income.

The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

RECLASSIFICATIONS
Sales and operating results by geographic area, presented in Note 21,
are prepared on a "customer basis," meaning these measures are reported in the
geographic area where the customer is located. Previously, this information
was reported on an "entity basis," meaning that the results were included where
the legal entity is located. Data for 1995 and 1994 have been reclassified to
conform with the 1996 presentation.

LONG-TERM CONTRACTS
Aerospace sales typically were under long-term contracts and included
cost-reimbursement and fixed-price contracts. Sales under cost-reimbursement
contracts were recognized for accounting purposes as costs were incurred and
included a proportion of the fees expected to be realized equal to the ratio of
costs incurred to date to total estimated costs. Sales under fixed-price
contracts were recognized for accounting purposes as the actual cost of work
performed relates to the estimate at completion. Cost or performance
incentives, which were incorporated in certain contracts, were recognized when
realization was assured and amounts could be reasonably estimated. Estimated
amounts for contract changes and claims were included in contract sales only
when realization was probable. Assumptions used for recording sales and
earnings were adjusted in the period of change to reflect revisions in contract
value and estimated costs. In the period in which it was determined that a
loss would be incurred on a contract, the entire amount of the estimated loss
was charged to income.

ENVIRONMENTAL EXPENDITURES
Environmental expenditures that pertain to current operations or
future revenues are expensed or capitalized according to the company's
capitalization policy. Expenditures for the remediation of an existing
condition caused by past operations that do not contribute to current or future
revenues are expensed. Liabilities are recognized for remedial activities when
the cleanup is probable and the cost can be reasonably estimated.

CASH AND CASH EQUIVALENTS
Cash in excess of operating requirements is invested in short-term,
income-producing instruments. Cash equivalents include commercial paper and
other securities with original maturities of 90 days or less. Book value
approximates fair value because of the short maturity of those instruments.

INVENTORIES
Inventories are stated at the lower of cost or market. Domestic
inventories are valued predominantly on the last-in, first-out (LIFO) method.
Foreign and certain domestic inventories, which in the aggregate represent 63%
of total inventories at December 31, 1996, are valued principally by the
average-cost method.





17
19
PROPERTY AND DEPRECIATION
Property, plant, and equipment are stated at cost. The company
changed to the straight-line method of depreciation, effective January 1, 1991,
for newly acquired processing facilities and equipment. Assets acquired before
then continue to be depreciated by accelerated methods. The company believes
that straight-line depreciation provides a better matching of costs and
revenues over the lives of the assets.

Maintenance, repairs, and minor renewals are charged to income; major
renewals and betterments are capitalized. Upon normal retirement or
replacement, the cost of property (less proceeds of sale or salvage) is charged
to income.

INCOME TAXES
Income taxes are determined in accordance with Statement of Financial
Accounting Standards (SFAS) No. 109, which requires an asset-and-liability
approach for financial accounting and reporting of income taxes. Changes in
enacted tax rates are reflected in the tax provision as they occur. A
valuation allowance is recorded to reduce deferred tax assets when realization
of a tax benefit is unlikely.

The company provides taxes on undistributed earnings of subsidiaries
and affiliates included in consolidated retained earnings to the extent such
earnings are planned to be remitted and not reinvested permanently.

FOREIGN CURRENCY TRANSLATION
With the exception of operations in countries with highly inflationary
economies, the financial statements of Hercules' non-U.S. entities are
translated into U.S. dollars using current rates of exchange, with gains or
losses included in the foreign currency translation adjustment account in the
stockholders' equity section of the balance sheet. The related allocation for
income taxes is not significant. For operations in countries with highly
inflationary economies, financial statements are translated at either current
or historical exchange rates, as appropriate. These adjustments, along with
gains and losses on currency transactions (denominated in currencies other than
local currency), are reflected in net income.

FINANCIAL INSTRUMENTS AND HEDGING
Derivative financial instruments are used to hedge risk caused by
fluctuating currency and interest rates. The company enters into
forward-exchange contracts and currency swaps to hedge foreign currency
exposure. Decisions regarding hedging are made on a case-by-case basis, taking
into consideration the amount and duration of the exposure, market volatility,
and economic trends. The company uses the fair-value method of accounting,
recording realized and unrealized gains and losses on these contracts
quarterly. They are included in other income (expense), net, except for gains
and losses on contracts to hedge specific foreign currency commitments, which
are deferred and accounted for as part of the transaction. Gains or losses on
contracts used to hedge the value of investments in certain non-U.S.
subsidiaries are accounted for under the deferral method and are included in
the foreign currency translation adjustment account. It is the company's
policy to match the term of financial instruments with the term of the
underlying designated item. If the designated item is an anticipated
transaction no longer likely to occur, gains or losses from the instrument
designated as a hedge are recognized in current period earnings. The company
does not hold or issue financial instruments for trading purposes. In the
Consolidated Statement of Cash Flow, the company reports the cash flows
resulting from its hedging activities in the same category as the related item
that is being hedged.

The company uses interest rate swap agreements to manage interest
costs and risks associated with changing rates. The differential to be paid or
received is accrued as interest rates change and is recognized in interest
expense over the life of the agreements. Counterparties to the forward
exchange, currency swap, and interest rate swap contracts are major financial
institutions. Credit loss from counterparty nonperformance is not anticipated.





18
20
STOCK-BASED COMPENSATION
Compensation costs attributable to stock option and similar plans are
recognized based on any difference between the quoted market price of the
stock on the date of grant over the amount the employee is required to pay to
acquire the stock (the intrinsic value method under Accounting Principles Board
[APB] Opinion 25). Such amount, if any, is accrued over the related vesting
period, as appropriate. SFAS No. 123, "Accounting for Stock-Based
Compensation," requires companies electing to continue to use the
intrinsic-value method to make pro forma disclosures of net income and earnings
per share as if the fair-value-based method of accounting had been applied.

LONG-LIVED ASSETS
Effective January 1, 1996, the company adopted SFAS No. 121,
"Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets
to be Disposed Of." The provisions of SFAS No. 121 require the company to
review its long-lived assets for impairment on an exception basis whenever
events or changes in circumstances indicate that the carrying amount of the
assets may not be recoverable through future cash flows. If it is determined
that an impairment loss has occurred based on expected future cash flows, then
the loss is recognized in the income statement. The adoption of SFAS No. 121
did not have an effect on the company's consolidated financial statements.






















19
21

HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

1. ACCOUNTS RECEIVABLE, NET
Accounts receivable, net, consists of: (Dollars in millions)



1996 1995
------------------------

Trade $327 $346
Other 71 85
------------------------
Total 398 431
Less allowance for doubtful accounts 4 5
------------------------
$394 $426
========================


At December 31, 1996, net trade accounts receivable from customers
located in the United States, Europe, the Americas, and Asia were $145 million,
$143 million, $27 million, and $8 million, respectively.

2. INVENTORIES

The components of inventories are: (Dollars in millions)


1996 1995
------------------------

Finished products $154 $168
Materials, supplies, and work in process 125 140
------------------------
$279 $308
========================


Inventories valued on the LIFO method were lower than if valued under the
average-cost method, which approximates current cost, by $33 million and $37
million at December 31, 1996 and 1995, respectively.

3. INVESTMENTS
Total equity investments in affiliated companies were $290 million at December
31, 1996, and $261 million at December 31, 1995. Dividends received from
affiliated companies were $11 million in 1996, $9 million in 1995, and $11
million in 1994.

Other investments, at cost or less, were $74 million and $83 million at
December 31, 1996 and 1995, respectively. Included in these amounts are
noncurrent marketable securities aggregating $33 million and $40 million for
the corresponding years. The company's investments in equity and debt
securities covered under the scope of SFAS No. 115, "Accounting for Certain
Investments in Debt and Equity Securities," are classified as "available for
sale." The value of these investments, based on market quotes, approximates
book values.













20
22
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

A summary of the results of operations and net assets for all affiliated
companies accounted for on the equity method is as follows:



(Dollars in millions)
1996 1995
--------------------------

Results of Operations
- ---------------------
Net sales $1,505 $1,222
Profit from operations 173 141
Net income 110 85


Net Assets
- ----------
Current assets 485 554
Other assets 809 720
--------------------------
Total assets 1,294 1,274

Current liabilities (379) (390)
Other liabilities (469) (535)
Interest of others (255) (190)
--------------------------



4. SHORT-TERM DEBT
A summary of short-term debt follows:


(Dollars in millions)
1996 1995
--------------------------

Commercial paper $265 $160
Banks 48 47
Current maturities of long-term debt -- --
--------------------------
$313 $207
==========================


Commercial paper is issued or renewed for varying periods, with interest
at prevailing market rates. Bank borrowings represent primarily foreign
overdraft facilities and short-term lines of credit, which are generally
payable on demand with interest at various rates. Book values of commercial
paper and bank borrowings approximate market value because of their short
maturity period.

At December 31, 1996, Hercules had $113 million of unused lines of credit
that may be drawn as needed, with interest at a negotiated spread over lenders'
cost of funds. Lines of credit in use at December 31, 1996, were $52 million.
Weighted-average interest rates on short-term borrowings at December 31, 1996
and 1995, were 5.51% and 6.78%, respectively.





21
23
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

5. LONG-TERM DEBT

A summary of long-term debt follows:



(Dollars in millions)
1996 1995
-------------------------------------

6.5% convertible subordinated debentures due 1999 (a) $ 2 $ 2
7.85% notes due 2000 25 25
6.625% notes due 2003 (b) 125 125
8% convertible subordinated debentures due 2010 (c) 41 41
Commercial paper (d) 50 50
Variable rate loans (e) 93 47
Other 9 8
-------------------------------------
345 298
Current maturities of long-term debt -- --
-------------------------------------
Net long-term debt $ 345 $ 298
=====================================


(a)Subordinated debentures are convertible into common stock at $11.67
per share and are redeemable at the option of the company at varying rates.

(b) Par value of $125 million issued June 1993.

(c) Subordinated debentures are convertible into common stock at
$14.90 per share and are redeemable at the option of the company at varying
rates. The annual sinking fund requirement of $5 million, beginning in 1996,
has been satisfied through conversions of debentures.

(d) The company has both the intent and the ability, through its
revolving credit agreement, to refinance this amount on a long-term basis.

(e) Uncollateralized bank borrowings with average maturities of 400
days, with interest at a negotiated spread over lenders' cost of funds.

The company has entered into a revolving credit and competitive
advance facility agreement with several banks providing for commitments that
terminate in 2000. Hercules may borrow up to a total of $380 million (of which
$65 million was available at December 31, 1996) at agreed-upon spreads over
various benchmark rates, such as the London Interbank Offered Rate (LIBOR).
This agreement requires the maintenance of certain financial ratios.

Long-term debt maturities during the next five years are $0 in 1997,
$98 million in 1998, $2 million in 1999, $28 million in 2000, and $0 in 2001.

6. SERIES PREFERRED STOCK
The series preferred stock is without par value and is issuable in series.
There are 2,000,000 shares authorized for issuance, none of which have been
issued.

7. COMMON STOCK

Hercules common stock has a stated value of $25/48, and 300,000,000 shares are
authorized for issuance. At December 31, 1996, a total of 12,658,657 shares
were reserved for issuance for the following purposes: 879,999 shares for
sales to the Savings Plan Trustee; 6,985,393 shares for the exercise of awards
under the Stock Option Plan; 485,225 shares for awards under incentive
compensation plans; 2,891,860 shares for conversion of debentures and notes;
and 1,416,180 shares for employee stock purchases.









22
24
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

For the company's stock repurchase program, from its start in 1991
through year-end 1996, the Board authorized the repurchase of up to 64,650,000
shares of company common stock. Of that total, 6,150,000 shares were intended
to satisfy requirements of various employee benefit programs. During this
period, a total of 54,590,935 shares of common stock was purchased in the open
market at an average price of $35.14 per share.

8. STOCK-BASED INCENTIVE PLANS

The incentive compensation plans provide for the grant of stock options and the
award of common stock and other market-based units to certain key employees and
nonemployee directors. Through 1994, shares of common stock awarded under
these plans normally were either restricted stock or performance shares.
During the restriction period, award holders have the rights of stockholders,
including the right to vote and receive cash dividends, but they cannot
transfer ownership. Shares are forfeited and revert to the company in the
event of employment termination, except in the case of death, disability,
retirement, or other specified events.

Restricted stock continues to be awarded with respect to certain
programs. In 1995, Hercules changed the structure of the long-term incentive
compensation plans to place a greater emphasis on shareholder value creation.
Instead of restricted stock and performance shares for key management
employees, the company uses regular stock options, performance-accelerated
stock options, and Cash Value Awards (performance-based awards denominated in
cash and payable in shares of common or restricted stock, subject to the same
restrictions and risk of forfeiture). The number of awarded shares outstanding
was 1,881,946; 1,691,546; and 3,269,250 at December 31, 1996, 1995, and 1994,
respectively.

Under the company's incentive compensation plans, 485,225 shares of
common stock were available for grant as options at December 31, 1996. Regular
stock options are granted at the market price on the date of grant and are
exercisable at various periods from one to five years after date of grant.
Performance-accelerated stock options are also granted at the market price on
the date of grant and are normally exercisable at nine and one-half years.
Exercisability may be accelerated based upon the achievement of predetermined
performance goals. Both regular and performance-accelerated stock options
expire 10 years after the date of grant.

The company applies APB Opinion 25 in accounting for its plans.
Accordingly, no compensation cost has been recognized for the plans in 1996,
1995, or 1994. The cost of stock awards and other market-based units, which is
charged to income over the restriction or performance period, amounted to $9
million for 1996; $81 million (including $39 million in the fourth quarter,
primarily related to the early vesting of certain long-term incentive
compensation programs) during 1995; and $41 million for 1994 (including a
fourth-quarter charge of $15 million related to increases in the company's
stock price and performance at above-target levels).







23
25
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS


Below is a summary of outstanding stock option grants under the
incentive compensation plans during 1994, 1995, and 1996:



Regular Performance-Accelerated
-----------------------------------------------------------------------
Weighted- Weighted-
Number of Average Number of Average
Shares Price Shares Price
------------ ------------- ------------ -------------

January 1, 1994 3,400,548 $18.04 -- --
Granted 872,700 $35.60 -- --
Exercised (348,438) $16.74 -- --
Forfeited (11,850) $14.23 -- --

- -----------------------------------------------------------------------------------------------------------
December 31, 1994 3,912,960 $22.01 -- --
Granted 648,949 $47.69 786,375 $48.54
Exercised (654,625) $22.24 -- --
Forfeited (24,100) $16.02 -- --

- -----------------------------------------------------------------------------------------------------------
December 31, 1995 3,883,184 $26.24 786,375 $48.54
Granted 673,450 $55.40 2,303,750 $49.66
Exercised (646,247) $21.29 -- --
Forfeited (800) $47.25 (14,319) $48.29

- -----------------------------------------------------------------------------------------------------------
December 31, 1996 3,909,587 $32.49 3,075,806 $49.38



The weighted-average fair value of regular stock options granted
during 1995 was $13.91 and $14.36 during 1996. The weighted-average fair value
of performance-accelerated stock options granted during 1995 and 1996 was
$11.17 and $10.23, respectively.

Following is a summary of regular stock options exercisable at
December 31, 1994, 1995, and 1996, and their respective weighted-average share
prices:



Weighted- Average
Number of Shares Exercise Price
---------------------------------------------

Options exercisable
December 31, 1994 2,242,950 $16.69

Options exercisable
December 31, 1995 2,567,445 $20.70

Options exercisable
December 31, 1996 2,636,457 $25.08



There were no performance-accelerated stock options exercisable at
December 31, 1994, 1995, and 1996.











24
26
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS


Following is a summary of regular stock options outstanding at
December 31, 1996:




Outstanding Options Exercisable Options
--------------------------------------------------------------------------------------
Weighted-
Number Average Weighted- Number Weighted-
Outstanding Remaining Average Exercisable Average
Exercise at Contractual Exercise at Exercise
Price Range 12/31/96 Life Price 12/31/96 Price
- ----------- --------------------------------------------------------------------------------------

$ 0 - $20 1,328,987 4.38 $14.86 1,238,987 $14.76
$21 - $30 516,010 6.33 $24.99 516,010 $24.99
$31 - $40 761,400 7.35 $35.50 594,480 $35.39
$41+ 1,303,190 8.71 $51.68 286,980 $48.45


The range of exercise prices for the performance-accelerated options
outstanding at December 31, 1996, is $47 to $61 with a weighted-average
contractual life of 9.28 years. The company estimates at December 31, 1996,
100% of such options will eventually vest.

Employee Stock Purchase Plan

The company's Employee Stock Purchase Plan is a qualified noncompensatory plan,
which allows eligible employees to acquire shares of common stock through
systematic payroll deductions. The plan consists of three-month subscription
periods, beginning July 1 of each year. The purchase price is 85% of the fair
market value of the common stock on either the first or last day of that
subscription period, whichever is lower. Purchases may range from 2% to 15% of
an employee's base salary each pay period, subject to certain limitations.
Currently, 1,416,180 shares of Hercules common stock are registered for offer
and sale under the plan. Shares issued at December 31, 1996 and 1995, were
383,820 and 306,032, respectively. The company applies APB Opinion 25 and
related interpretations in accounting for its Employee Stock Purchase Plan.
Accordingly, no compensation cost has been recognized for the Employee Stock
Purchase Plan for 1996, 1995, and 1994.

Had compensation cost for the company's Stock-Based Incentive Plans
and Employee Stock Purchase Plan been determined on the basis of fair value
according to SFAS No. 123, the fair value of each option granted would be
estimated on the grant date using the Black-Scholes option pricing model. The
following assumptions would be used in estimating fair value for 1996 and 1995:


Employee
Performance- Stock
Regular Accelerated Purchase
Assumption Plan Plan Plan
------------------------ ------------ ------------ ------------

Dividend yield 3.0% 3.0% 3.0%
Risk-free interest rate 6.42% 6.10% 5.55%
Expected life 8 yrs. 5 yrs. 3 mos.
Expected volatility 21.9% 20.6% 22.7%














25
27
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS

The company's net income and earnings per share for 1996 and 1995
would approximate the pro forma amounts below:



(Dollars in millions, except per share)

1996 1995
-----------------------------

Net income
As reported $325 $333
==============================

Pro forma $317 $329
==============================

Primary earnings per share
As reported $3.04 $2.93
==============================

Pro forma $2.97 $2.90
==============================


The effects of applying SFAS No. 123 in this pro forma disclosure are
not indicative of future amounts. SFAS No. 123 does not apply to awards prior
to 1995, and additional awards in future years are anticipated.

9. ADDITIONAL BALANCE SHEET DETAIL



(Dollars in millions)

1996 1995
----------------------------

Property, plant, and equipment
Land $ 21 $ 25
Buildings and equipment 2,247 2,456
Construction in progress 81 84
----------------------------
Total 2,349 2,565
Accumulated depreciation and amortization 1,484 1,565
----------------------------
Net property, plant, and equipment $ 865 $ 1,000
============================

Accrued expenses
Payroll and employee benefits $ 36 $ 68
Income taxes payable 20 50
Other 185 245
----------------------------
Accrued expenses $ 241 $ 363
============================



10. PENSION BENEFITS
Hercules and its consolidated subsidiaries maintain various defined benefit
pension plans covering substantially all employees. Benefits for most plans
are based on average final pay and years of service, while benefits for certain
represented locations are based on stated amounts and years of service. The
company's funding policy, consistent with statutory requirements and tax
considerations, is based on actuarial computations using the Entry Age Normal
method of calculation.















26
28
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS

Net periodic pension cost includes the following components:



(Dollars in millions)

1996 1995 1994
--------------------------------------------------------

Service cost (benefits earned
during the year) $ 19 $ 18 $ 28
Interest cost on projected
benefit obligation 77 80 100
Return on plan assets (139) (223) 3
Plan deferrals and amortization 46 132 (111)
Amortization of transition asset (14) (15) (19)
--------------------------------------------------------
Net periodic pension expense (credit) $ (11) $ (8) $ 1
========================================================


The company's pension plans have assets in excess of the accumulated
benefit obligation. Plan assets include domestic and international equity and
fixed income securities. The following table presents a reconciliation of the
funded status of the pension plans to prepaid pension expense:



(Dollars in millions)
1996 1995
-----------------------------------

Plan assets at fair value $1,168 $1,098
-----------------------------------
Actuarial present value of benefit obligations:
Accumulated benefit obligation
(vested, 1996--$911; 1995--$893) 948 936
Effect of increase in compensation 98 122
-----------------------------------
Projected benefit obligation 1,046 1,058
-----------------------------------
Plan assets in excess of projected benefit obligation 122 40
Unrecognized net loss 90 160
Unrecognized prior service cost 34 42
Unrecognized transition asset (53) (67)
-----------------------------------
Prepaid pension expense $ 193 $ 175
===================================


Significant assumptions used in determining pension obligations, and
the related pension expense, include a weighted-average discount rate of 7.75%
at December 31, 1996, and 7.25% at December 31, 1995, and an assumed rate of
increase in future compensation of 4.5% at both dates. The discount rate
during 1996 was changed to 8% on July 1. The discount rate changes were made
in response to interest rate changes in the economy. The expected long-term
rate of return on plan assets was 9.25% for 1996 and 9% for 1995.

The change in assumptions decreased the accumulated and projected
benefit obligations by approximately $42 million and $51 million, respectively.

On March 15, 1995, Hercules transferred pension plan assets of $306
million to an Alliant Techsystems pension plan in connection with the Aerospace
divestiture. The underlying liabilities also were transferred to Alliant. The
transfer of assets and liabilities resulted in curtailment and settlement
losses of $16 million and $42 million, respectively, which were reflected in
the net gain on the sale of the Aerospace segment. (See Note 14.) The
settlement loss included a reduction of $28 million in the unrecognized
transition asset.

11. OTHER POSTRETIREMENT BENEFITS

Hercules provides certain defined benefit postretirement health care and life
insurance benefits to retired employees. Substantially all employees are
covered and become eligible for these benefits upon satisfying the appropriate
age and service requirements.










27
29
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

The following provides a reconciliation of the accumulated
postretirement benefit obligation (APBO) to the liabilities reflected in the
company's balance sheet at December 31, 1996 and 1995:



(Dollars in millions)

1996 1995
----------------------------

Accumulated postretirement benefit obligation:
Retirees $112 $153
Fully eligible employees 10 11
Other employees 19 19
----------------------------
Total accumulated postretirement benefit obligation 141 183
Plan assets at fair value 9 9
----------------------------
APBO in excess of plan assets 132 174
Unrecognized prior service benefit 55 33
Unrecognized gain on plan assets 2 1
Unrecognized actuarial loss (15) (22)
----------------------------
Accrued postretirement benefit cost 174 186
Amount included in accrued expenses -- other (20) (21)
----------------------------
Other postretirement benefits $154 $165
============================


The postretirement plans are contributory. In August 1993, the company
established a Voluntary Employees' Beneficiary Association (VEBA) Trust and
contributed $10 million to fund postretirement benefits for eligible employees.
Benefits for retirees not eligible under the Trust continue to be paid by the
company. The company periodically obtains reimbursement from the Trust for
claims paid by the company that are eligible for reimbursement. In 1996 and
1995, $2 million in reimbursements were received from the Trust. The plan
assets are invested primarily in equity funds. The weighted average of the
expected long-term rate of return on plan assets was 9.25% and 9% on December
31, 1996 and 1995, respectively.

In January 1994, the company implemented managed care medical and
pharmacy programs for retirees. These programs reduced the accumulated
postretirement benefit obligation by $8 million. In February 1993, the company
modified its health care benefits. The changes provided for increased
cost-sharing by current and future retirees. The plan modifications reduced
the accumulated postretirement benefit obligation by $62 million. These
amounts are being amortized over the average remaining service lives of the
company's active employees. The components of net periodic benefit costs have
been reduced by $7 million and $8 million in 1996 and 1995, respectively, as a
result of these changes.

In 1996, Medicare Risk HMOs were offered to certain retiree groups. This
initiative will be expanded in 1997 and thereafter. This plan change reduced
the accumulated postretirement benefit obligation by $29 million, which will be
amortized over the average remaining service lives of the company's active
employees. The components of net periodic benefit costs have been reduced by
$5 million in 1996 as a result of this change.



(Dollars in millions)
1996 1995
----------------------------

Service cost (benefits attributed to service during the year) $ 1 $ 1
Interest cost on accumulated postretirement benefit obligation 11 15
Plan deferrals and amortization (4) (2)
Return on plan assets (2) (3)
----------------------------
Net periodic postretirement benefit cost $ 6 $ 11
============================

The weighted-average discount rate used to estimate the accumulated
postretirement benefit obligation was 7.75% at December 31, 1996, and 7.25% at
December 31, 1995. The discount rate during 1996 was changed to 8% on July 1.
The discount rate changes were made in response to interest rate changes in the
economy.











28
30
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

The assumed health care cost trend rate at December 31, 1996, was 6%
for those under age 65 and 5% for those over age 65, decreasing to 4.5% in 1999
and thereafter. The assumed health care cost trend rate at December 31, 1995,
was 8%, decreasing to 5% in 1998 and thereafter. At December 31, 1996 and
1995, the assumed compensation increases for life insurance were based on
graded scales averaging 4.4% for salaried employees and 3.4% for wage
employees. The change in the discount rate, return on assets, and health care
trend rate assumptions decreased the accumulated postretirement benefit
obligation by $5 million and the net periodic benefit costs by $1 million in
1996.

A 1% increase in the assumed health care cost trend rate would have
increased the accumulated obligation as of December 31, 1996, and the net
benefit cost for 1996 by $6 million and $1 million, respectively, and $11
million and $1 million, respectively, as of December 31, 1995.

As a result of the sale of the Aerospace business, the company
recognized a curtailment gain in 1995 of $25 million, which was reflected in
the net gain on the disposition of the Aerospace segment. (See Note 14.)

12. OTHER OPERATING EXPENSES (INCOME), NET

Other operating expenses (income), net, includes probable recoveries related to
environmental remediation of $13 million and reduction in the estimated loss on
the divestiture of the Composite Products Division of $5 million. Other
operating expenses (income), net, include environmental cleanup costs of $35
million in 1995 and $20 million in 1994, principally for nonoperating sites.
The 1995 expense also includes employee separation costs and write-offs of $4
million and a fourth-quarter charge of $8 million related to estimated losses
on the Composite Products divestiture. Additionally, other operating expenses
(income), net, in 1994 included employee separation costs from a corporate-wide
early retirement incentive option, involuntary terminations, and write-offs of
$19 million.

13. INTEREST AND DEBT EXPENSE

Interest and debt costs are summarized as follows:



(Dollars in millions)
1996 1995 1994
----------------------------------------------

Costs incurred $40 $33 $36
Amount capitalized 5 5 8
----------------------------------------------
Amount expensed 35 $28 $28
==============================================


14. OTHER INCOME (EXPENSE), NET

Other income (expense), net, consists of the following:



(Dollars in millions)
1996 1995 1994
----------------------------------------------

Interest income $ 5 $ 9 $ 8
Net gains on dispositions 22 132 14
Miscellaneous expense, net (1) (12) (31)
----------------------------------------------
26 $ 129 $ (9)
==============================================


Net gains on dispositions in 1996 reflect the sale of real estate and
the fourth-quarter sale of a product line. In 1995, net gains on dispositions
primarily reflect the sale of the Aerospace segment, $39 million, and the
fourth-quarter sale of the Electronics & Printing Division of the Food &
Functional Products segment, $85 million. In 1994, net gains on dispositions
primarily reflect the sale of the company's interests in affiliated companies.
Miscellaneous expense, net, includes net foreign currency gains (losses) of $11
million, ($16) million, and ($9) million in 1996, 1995, and 1994, respectively.













29
31
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

15. INCOME TAXES

The domestic and foreign components of income before taxes are presented below:



(Dollars in millions)
1996 1995 1994
----------------------------------------------

Domestic $250 $297 $243
Foreign 235 208 165
----------------------------------------------
$485 $505 $408
==============================================


A summary of the components of the tax provision follows:



(Dollars in millions)
1996 1995 1994
----------------------------------------------

Currently payable
U.S. federal $ 33 $122 $83
Foreign 60 62 46
State 9 1 6

Deferred
Domestic 41 (15) (5)
Foreign 17 2 4
----------------------------------------------
Provision for income taxes $160 $172 $134
==============================================


Deferred tax liabilities (assets) at December 31 consist of:



(Dollars in millions)
1996 1995
------------------------------

Depreciation $ 161 $ 156
Prepaid pension 76 72
Inventory 10 9
Other 24 16
------------------------------
Gross deferred tax liabilities 271 253
------------------------------
Postretirement benefits other than pensions (71) (79)

Accrued expenses (88) (98)
Loss carryforwards (16) (16)
Other (18) (40)
------------------------------
Gross deferred tax assets (193) (233)
------------------------------
Valuation allowance 15 15
------------------------------
$ 93 $ 35
==============================


During 1996, the provision for income taxes was favorably affected by
utilization of tax loss carryforwards. In 1995, the provision was favorably
affected by increased utilization of foreign tax credits and a state income tax
settlement related to the prior year sale of an investment. The 1994 rate
included recognition of $4 million of R&E credit related to research and
development expenditures incurred on certain government contracts.







30
32
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS

A reconciliation of the U.S. statutory income tax rate to the effective
rate follows:



1996 1995 1994
---------------------------------------------

U.S. statutory income tax rate 35% 35% 35%
R&E tax credit -- -- (1)
Foreign dividends net of credits -- (1) 1
State taxes 1 1 1
Utilization of operating losses (2) -- --
Valuation allowance -- -- (1)
Other (1) (1) (2)
---------------------------------------------
Effective tax rate 33% 34% 33%
=============================================


The undistributed earnings of subsidiaries and affiliates on which no
provision for foreign withholding or U.S. income taxes has been made amounted
to $428 million at December 31, 1996. U.S. and foreign income taxes that would
be payable if such earnings were distributed may be lower than the amount
computed at the U.S. statutory rate because of the availability of tax credits.

16. EARNINGS PER SHARE

Primary earnings per share are calculated on the basis of the average number of
common and common-equivalent shares, using net income adjusted to reflect the
elimination of interest expense, net of taxes, on the 6.5% convertible
debentures. Shares used in the calculation are as follows:


1996 107,025,499
1995 113,691,438
1994 120,040,209


Fully diluted earnings per share, which additionally assumes conversion
of the 8% convertible subordinated debentures, are not materially different
from primary earnings per share. Equivalent shares are increased by an
additional 2,739,070 in 1996, 3,160,537 in 1995, and 4,900,548 in 1994, and net
income is further adjusted to eliminate interest expense, net of taxes, of $2
million for 1996 and 1995, and $4 million for 1994.

17. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

Notional Amounts and Credit Exposure of Derivatives

The notional amounts of derivatives summarized below do not represent amounts
exchanged by the parties and, thus, are not a measure of the exposure of the
company through its use of derivatives. The amounts exchanged are calculated
on the basis of the notional amounts and the other terms of the derivatives,
which relate to interest rates or exchange rates.

Interest Rate Risk Management

Beginning in March 1996, the company entered into a series of agreements, which
effectively converted floating rate debt into debt with a fixed rate ranging
from 6.03% to 6.15% per year. Agreements mature from 1998 through the fourth
quarter of 2000. During the reporting period, these agreements expired: a
1992 three-year amortizing interest rate swap, which converted 5.52% fixed-rate
debt to floating-rate debt, and 1993 agreements, which converted floating-rate
debt into debt with a fixed rate ranging from 4.92% to 7.52% per year. For the
years 1996, 1995, and 1994, these contracts resulted in a less than 1% change
in the effective interest rate on the weighted-average notional principal
amounts outstanding. The aggregate notional principal amounts at the end of
1996 and 1995 were $125 million and $160 million, respectively.







31
33
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS

The following table indicates the types of swaps used and their
weighted-average interest rates:



(Dollars in millions)

1996 1995
--------------------------

Pay fixed on swaps notional amount (at year-end) $125 $160
Average pay rate 6.1% 6.1%
Average receive rate 5.5% 6.0%


Foreign Exchange Risk Management

The company selectively uses foreign currency forward contracts to offset the
effects of exchange rate changes on reported earnings, cash flow, and net asset
positions. The primary exposures are denominated in Danish kroner, Dutch
guilder, Belgian franc, British pound sterling, and the German mark. Some of
the contracts involve the exchange of two foreign currencies, according to
local needs in foreign subsidiaries. The term of the currency derivatives is
rarely more than one year. At December 31, 1996 and 1995, the company had
outstanding forward-exchange contracts to purchase foreign currencies
aggregating $17 million and $24 million and to sell foreign currencies
aggregating $184 million and $282 million, respectively. Non-U.S. dollar
cross-currency trades aggregated $500 million in 1996 and $303 million in 1995.
The forward- exchange contracts outstanding at December 31, 1996, will mature
during 1997. No currency swap agreements were outstanding at December 31, 1996
or 1995. Fair values of derivative contracts are indicative of cash that would
have been required had settlement been December 31, 1996.

Fair Values

The following table presents the carrying amounts and fair values of the
company's financial instruments at December 31, 1996 and 1995:



(Dollars in millions)

1996 1995
-------------------------------------------------------------
Carrying Fair Carrying Fair
Amount Value Amount Value
-------------------------------------------------------------

Investment securities $ 33 $ 33 $ 40 $ 40
Long-term debt (345) (430) (298) (425)
Foreign exchange contracts 3* 3 -- --
Interest rate swap contracts -- -- (1)* (2)


*The carrying amount represents the net unrealized gain or net
interest payable associated with the contracts at the end of the
period.

Basis of Valuation

Investment securities: Quoted market prices.

Long-term debt: Present value of expected cash flows related to existing
borrowings discounted at rates currently available to the company for long-term
borrowings with similar terms and remaining maturities.

Foreign exchange contracts: Year-end exchange rates.

Interest rate swap contracts: Bank or market quotes or discounted cash flows
using year-end interest rates.

18. PENDING DIVESTITURE

In February 1997, the company announced the signing of an agreement by
Tastemaker, the 50%-owned flavors joint venture, to divest its operating assets
to Roche, the Swiss parent company of Givaudan-Roure.














32
34
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

The transaction is expected to result in a financial gain. In conjunction with
the transaction, it is management's intention to increase leverage so that the
net cash value of the transaction to Hercules approximates $550 million.
Equity income of affiliated companies includes Tastemaker earnings of $32
million in 1996, $28 million in 1995, and $22 million in 1994.

19. DIVESTITURES

In June 1996, the company sold its Composite Products Division for $141 million
in cash. Net sales and operating profits (losses) of this business were $49
million and $8 million, respectively, in 1996, $98 million and ($2) million,
respectively, in 1995, and $86 million and ($12) million, respectively, in
1994. In March 1995, the company sold its Aerospace segment to Alliant
Techsystems for $247 million in cash and 3.86 million shares of Alliant common
stock. Net sales and operating profits of this segment were $123 million and
$13 million, respectively, in 1995 and $657 million and $110 million,
respectively, in 1994. In December 1995, Hercules sold its Electronics &
Printing Division of the Food & Functional Products segment to MacDermid
Incorporated for $100 million in cash and $30 million in preferred stock. Net
sales and operating profit of this division were $66 million and $16 million in
1995, respectively, and $67 million and $12 million, respectively, in 1994.
During 1994, the company completed the divestiture of its Packaging Films and
Liquid Molding Resins business units for $173 million in cash. Net sales and
operating results of these units were $47 million and $0, respectively, for the
year ended December 31, 1994.

20. COMMITMENTS AND CONTINGENCIES

Leases:

Hercules has operating leases (including office space, transportation, and data
processing equipment) expiring at various dates. Rental expense was $31
million in 1996, $35 million in 1995, and $41 million in 1994.

At December 31, 1996, minimum rental payments under noncancelable
leases aggregated $306 million with subleases of $10 million. A significant
portion of these payments relates to a long-term operating lease for corporate
office facilities. The net minimum payments over the next five years are $21
million in 1997, $21 million in 1998, $22 million in 1999, $19 million in 2000,
and $18 million in 2001.

Environmental:

Hercules has been identified as a potentially responsible party (PRP) by U.S.
federal and state authorities for environmental cleanup at numerous sites. The
estimated range of the reasonably possible costs of remediation is between $70
million and $246 million. The actual costs will depend upon numerous factors,
including the number of parties found liable at each environmental site and
their ability to pay, the actual method of remediation, outcome of negotiations
with regulatory authorities, outcome of litigation, changes in environmental
laws and regulations, technological developments, and the years of remedial
activity required, which could range up to 30 years. Hercules becomes aware of
sites in which it may be, but has not yet been named, a PRP principally through
its knowledge of investigation of sites by the U.S. Environmental Protection
Agency (EPA) or other government agency or through correspondence with
previously named PRPs requesting information on Hercules' activities at sites
under investigation. Hercules brought suit in 1992 against its insurance
carriers for past and future costs for remediation of certain environmental
sites. Hercules has not included any insurance recovery in the estimates
above.

Hercules has established procedures for identifying environmental
issues at Hercules plant sites. Environmental coordinators, a designated
position at all operating facilities, are familiar with environmental laws and
regulations and are resources for identification of environmental issues.
Hercules also has an environmental audit program, which is designed to identify
environmental issues at operating plant sites. Through these programs,
Hercules identifies potential environmental, regulatory, and remedial issues.









33
35
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

Litigation over liability at Jacksonville, Arkansas, the most
significant site, has been pending since 1980. As a result of a pretrial court
ruling in October 1993, Hercules has been held jointly and severally liable for
costs incurred, and for future remediation costs, at the Jacksonville site by
the District Court, Eastern District of Arkansas (the Court). Appeal of the
Court's ruling will be filed promptly after issuance of a final court order.
In November 1993, an advisory jury found Uniroyal Chemical, Ltd., liable for
the Jacksonville site, but also found that Uniroyal had proven a reasonable
basis for allocation of responsibility. That same advisory jury found Standard
Chlorine of Delaware is not a liable party for the Jacksonville site. The
Court may take the jury's findings into consideration when reaching its
decision regarding these parties. The Court has not entered its ruling on the
liability of Uniroyal and Standard Chlorine. Appeals of the Court's expected
rulings with respect to Uniroyal and Standard Chlorine are probable.

Other defendants in this litigation have either settled with the
government or, in the case of the Department of Defense (DoD), have not been
held liable. Hercules appealed the Court's order finding the DoD not liable.
On January 31, 1995, the 8th Circuit Court of Appeals upheld the Court's order.
Hercules filed a petition to the U.S. Supreme Court requesting review and
reversal of the 8th Circuit Court ruling. This petition was denied on June 26,
1995, and the case was remanded to the District Court for further proceedings.

Hercules' potential costs for remediation of the Jacksonville site are
presently estimated between $29 million and $109 million. These costs are
based on Hercules' assessment of potential liability, the level of
participation by other PRPs, and current estimates of remediation costs.

At December 31, 1996, the accrued liability for environmental
remediation represents management's best estimate of the probable and
reasonably estimable costs related to environmental remediation. The extent of
liability is evaluated quarterly. The measurement of the liability is
evaluated based on currently available information, including the progress of
remedial investigation at each site and the current status of negotiations with
regulatory authorities regarding the method and extent of apportionment of
costs among other PRPs. The company does not anticipate that its financial
condition will be materially affected by environmental remediation costs in
excess of amounts accrued, although quarterly or annual operating results could
be materially affected.

Litigation:

Hercules is a defendant in numerous lawsuits that arise out of, and are
incidental to, the conduct of its business. In these legal proceedings, no
director, officer, or affiliate is a party or a named defendant. These suits
concern issues such as product liability, contract disputes, labor-related
matters, patent infringement, environmental proceedings, property damage, and
personal injury matters. Hercules also is a defendant in two Qui Tam ("Whistle
Blower") lawsuits brought by former employees of the Aerospace segment sold to
Alliant Techsystems. One suit involves allegations relating to submission of
false claims and records, delivery of defective products, and a deficient
quality control program. The other suit involves allegations of mischarging of
work performed under government contracts, misuse of government equipment,
other acts of financial mismanagement, and wrongful termination claims. The
government, after investigation of the allegations, declined to intervene in
either lawsuit. The first of these lawsuits is presently scheduled for trial
in 1997. While damages claimed in the first suit are material, the company
believes no damages were incurred by the government, no false claims were made
to the government, and alleged damages are speculative and insupportable. The
damages in the second suit were not defined. The company intends to vigorously
defend these lawsuits.

Hercules is also a defendant in a class action (approximately 140
members) of property owners adjacent to its Brunswick, Georgia, plant. The
class members seek property impairment related damages including damages for
alleged decrease in property values caused by the presence of toxaphene (a
pesticide manufactured at the plant from 1948 to 1980) on their properties.
The class members claim that the toxaphene resulted from manufacturing
operations. In February 1997, a settlement was reached, subject to the
approval of the court. The amount is not material to the financial condition
of the company.







34
36
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

While it is not feasible to predict the outcome of all pending suits
and claims, management does not anticipate that the ultimate resolution of
these matters will have a material effect upon the consolidated financial
position of Hercules, although the resolution of any of the matters during a
specific period could have a material effect on the quarterly or annual
operating results for that period.

21. OPERATIONS BY INDUSTRY SEGMENT AND GEOGRAPHIC AREA

Hercules operates worldwide, manufacturing chemical specialty products. Core
businesses are Aqualon, Paper Technology, Resins, Food Gums, and Fibers.
Principal products and markets include water-soluble polymers for latex paints,
wet-strength and sizing aids for paper production, rosin and hydrocarbon resins
for adhesives, natural gums for food and beverages, and polypropylene fiber for
disposable diapers.

Sales to the U.S. Government and other customers under government
contracts, principally by the divested Aerospace segment, aggregate $123
million in 1995 and $602 million in 1994. Intersegment sales are eliminated
and insignificant.

Operating results are prepared on a "customer basis," meaning that net
sales and profit (loss) from operations are included in the geographic area
where the customer is located. Assets are included in the geographic area in
which the producing entities are located. A direct sale from the United States
to an unaffiliated customer in Europe is reported as a European sale.
Interarea sales between Hercules locations are made at transfer prices that
approximate market price and have been eliminated from consolidated net sales.
Operating profit for the individual area includes the full profitability
generated by sales of Hercules products imported from other geographic areas.

Identifiable assets include net trade accounts receivable,
inventories, and net property, plant, and equipment.

Consolidated foreign subsidiaries had net assets (including
translation adjustment) of $522 million at December 31, 1996, $605 million at
December 31, 1995, and $574 million at December 31, 1994, and net income of
$158 million in 1996, $144 million in 1995, and $115 million in 1994.

Direct export sales from the United States to unaffiliated customers
were $295 million, $291 million, and $286 million for 1996, 1995, and 1994,
respectively.

















35
37
HERCULES INCORPORATED
NOTES TO FINANCIAL STATEMENTS
- -------------------------------------------------------------------------------

21. OPERATIONS BY INDUSTRY SEGMENT AND GEOGRAPHIC AREA Continued

(Dollars in millions)



Food &
Chemical Functional Corporate &
Industry Segments Specialties Products Aerospace* Other Total
- -------------------------------------------------------------------------------------------------------------

1996
- -------------------------------------------------------------------------------------------------------------
Net sales $1,085 $ 923 $ -- $ 52 $2,060
Profit from operations 205 217 -- 19 441
Identifiable assets 753 701 -- 13 1,467
Capital expenditures 61 55 -- 4 120
Depreciation 46 54 -- 6 106

- -------------------------------------------------------------------------------------------------------------
1995
Net sales 1,154 1,046 123 104 2,427
Profit (loss) from operations 211 187 13 (48) 363
Identifiable assets 748 747 -- 165 1,660
Capital expenditures 61 43 6 7 117
Depreciation 51 67 2 13 133

- -------------------------------------------------------------------------------------------------------------
1994
Net sales 1,081 945 657 138 2,821
Profit (loss) from operations 197 148 110 (36) 419
Identifiable assets 715 780 543 83 2,121
Capital expenditures 52 100 9 3 164
Depreciation 49 53 35 11 148





United
Geographic Areas States Europe Americas** Asia Pacific Total
- -------------------------------------------------------------------------------------------------------------

1996
- -------------------------------------------------------------------------------------------------------------
Net sales to
unaffiliated customers $ 929 $726 $223 $182 $2,060
Profit from operations 177 151 65 48 441
Identifiable assets 767 581 86 33 1,467

1995
- -------------------------------------------------------------------------------------------------------------
Net sales to
unaffiliated customers 1,241 762 243 181 2,427
Profit from operations 92 152 65 54 363
Identifiable assets 905 655 80 20 1,660

1994
- -------------------------------------------------------------------------------------------------------------
Net sales to
unaffiliated customers 1,763 643 252 163 2,821
Profit from operations 201 100 60 58 419
Identifiable assets 1,406 622 77 16 2,121




* Reflects results of operations through March 14, 1995.
** Ex-U.S.A.





36
38
Hercules Incorporated
Summary of Quarterly Results (Unaudited)
(Dollars in millions, except per share)



1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Year
1996 1995 1996 1995 1996 1995 1996 1995 1996 1995
- -------------------------------------------------------------------------------------------------------------------------

OPERATING RESULTS
Net sales $503 $693 $545 $614 $518 $571 $494 $549 $2,060 $2,427
Cost of sales 326 462 354 392 327 367 313 370 1,320 1,591
SG&A and R&D 80 109 79 102 78 94 81 121 318 426
Other operating expenses (income), net (1) 8 (5) 3 (14) 5 1 31 (19) 47
---------------------------------------------------------------------------------

Profit from operations 98 114 117 117 127 105 99 27 441 363
Equity income 14 7 16 14 12 11 11 9 53 41
Interest and debt expense 8 7 9 7 9 7 9 7 35 28
Other income (expense), net 12 27 8 (8) (2) 11 8 98 26 129
---------------------------------------------------------------------------------

Income before taxes 116 141 132 116 128 120 109 127 485 505
Income taxes 40 52 44 37 43 40 33 43 160 172
---------------------------------------------------------------------------------

Net income $ 76 $ 89 $ 88 $ 79 $ 85 $ 80 $ 76 $ 84 $325 $ 333
=================================================================================

Earnings per share $.70 $.76 $ .81 $.70 $.80 $.72 $.73 $.75 $3.04 $2.93
=================================================================================

NET SALES BY INDUSTRY SEGMENT
Chemical Specialties $252 $289 $275 $299 $280 $286 $278 $280 $1,085 $1,154
Food & Functional Products 228 257 242 287 237 260 216 242 923 1,046
Aerospace -- 123 -- -- -- -- -- -- -- 123 *
Corporate & other 23 24 28 28 1 25 -- 27 52 104
---------------------------------------------------------------------------------
Total $503 $693 $545 $614 $518 $571 $494 $549 $2,060 $2,427
=================================================================================

PROFIT (LOSS) FROM OPERATIONS
BY INDUSTRY SEGMENT
Chemical Specialties $ 45 $ 59 $ 53 $ 61 $ 55 $ 55 $ 52 $ 35 $205 $211
Food & Functional Products 51 47 58 59 60 56 48 25 217 187
Aerospace -- 13 -- -- -- -- -- -- -- 13 *
Corporate & other 2 (5) 6 (3) 12 (6) (1) (33) 19 (48)
---------------------------------------------------------------------------------
Total $ 98 $114 $117 $117 $127 $105 $ 99 $ 27 $441 $363
=================================================================================








* Reflects results of operations through March 14, 1995.













37
39
Principal Consolidated, Wholly Owned Subsidiaries (Directly or Indirectly)


ARGENTINA
Hercules Fibers Argentina S.A., Buenos Aires

AUSTRIA
Patex Chemie GmbH, Traun

THE BAHAMAS
Hercules International Trade Corporation Limited (HINTCO), Nassau

BELGIUM
Hercules Belgium N.V., Doel/Beringen
S.A. Hercules Europe N.V., Brussels

BERMUDA
Curtis Bay Insurance Co., Ltd., Hamilton

BRAZIL
Hercules do Brasil Produtos Quimicos Ltda., Sao Paulo

CANADA
Genu Products Canada Ltd., Pubnico, Nova Scotia
Hercules Canada Inc., Mississauga, Ontario

COLOMBIA
Quimica Hercules de Colombia S.A., Bogota

CZECH REPUBLIC
Hercules CZ s.r.o., Prague

DENMARK
Copenhagen Pectin A/S, Lille Skensved

ENGLAND
Hercules Limited, Surrey

FINLAND
Oy Hercofinn Ab, Helsinki

FRANCE
Aqualon France B.V., Rueil
Hercules S.A., Rueil

GERMANY
Hercules GmbH, Dusseldorf
Pomosin GmbH, Grossenbrode

HONG KONG
Hercules China Limited, Hong Kong

ITALY
Hercules Italia S.p.A., Milan

JAPAN
Hercules Japan Ltd., Tokyo

MEXICO
Hercules Fibras de Mexico, S.A. de C.V., Altamira, Tampico
Quimica Hercules, S.A. de C.V., Mexico City

THE NETHERLANDS
Hercules B.V., Rijswijk

SINGAPORE (REPUBLIC OF)
Hercules Singapore Pte Ltd., Singapore

SPAIN
Hercules Quimica, S.A., Tarragona

SWEDEN
Hercules AB, Goteborg

VIRGIN ISLANDS
Hercules Overseas Corporation, St. Thomas









38
40

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE:
Not Applicable.



PART III


ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT:
Information regarding directors and nominees for directors of the
company is included under the caption entitled "Re-election of Directors" on
page 3 of the Proxy Statement and is incorporated herein by reference.
Information regarding executive officers begins on page 10 of that report.

Disclosure of information for directors, officers, and other persons
not meeting the timely reporting requirements under section 16(a) of the
Exchange Act is contained in the Proxy Statement under the caption entitled
"Section 16(A) Beneficial Ownership Report Compliance" on page 23 and is
incorporated herein by reference.


ITEM 11. EXECUTIVE COMPENSATION:
Information regarding executive compensation of Hercules' directors
and executive officers is included in the Proxy Statement under the caption
entitled "Board Compensation" on page 9, and the caption entitled "Report of
the Compensation Committee" on pages 12 through 16, respectively, and is
incorporated herein by reference.


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT:
Information regarding beneficial ownership of the Common Stock by
certain beneficial owners and by management of the company is included under
the caption entitled "Beneficial Ownership" on page 17 of the Proxy Statement
and is incorporated herein by reference.


ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS:
In 1996, no director or officer had an involvement in such
transactions of a nature or magnitude to require disclosure under the
applicable SEC thresholds.















39
41
PART IV


ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND
REPORTS ON FORM 8-K:

(a) Documents filed as part of this Report:

1. Financial Statements

These documents are listed in the Index to Consolidated Financial
Statements. See Item 8.

2. Financial Statement Schedules:

All schedules are omitted because they are not applicable, not
required, or the information required is either presented in the
Notes to Financial Statements or has not changed materially from
that previously reported.

3. Exhibits:

A complete listing of exhibits required is given in the Exhibit
Index which precedes the exhibits filed with this Report.

(b) Reports on Form 8-K.

Hercules was not required to file any reports on Form 8-K for the
quarter ended December 31, 1996.















40
42
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized on March 27, 1997.


HERCULES INCORPORATED

By GEORGE MACKENZIE
-------------------------------------
George MacKenzie, Senior Vice
President
and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant in the capacities indicated on March 27, 1997.

PRINCIPAL EXECUTIVE OFFICER AND DIRECTOR:
Chairman and Chief Executive Officer R. KEITH ELLIOTT
----------------------------------
R. Keith Elliott


PRINCIPAL FINANCIAL OFFICER:
Senior Vice President and GEORGE MACKENZIE
Chief Financial Officer ----------------------------------
George MacKenzie

PRINCIPAL ACCOUNTING OFFICER:
Vice President and Controller VIKRAM JOG
----------------------------------
Vikram Jog

DIRECTORS:


VINCENT J. CORBO RALPH L. MACDONALD, JR.
- ---------------------------------- ----------------------------------
Vincent J. Corbo Ralph L. MacDonald, Jr.




RICHARD M. FAIRBANKS, III H. EUGENE MCBRAYER
- ---------------------------------- ----------------------------------
R. M. Fairbanks, III H. Eugene McBrayer


EDITH E. HOLIDAY PAULA A. SNEED
- ---------------------------------- ----------------------------------
Edith E. Holiday Paula A. Sneed


ROBERT G. JAHN LEE M. THOMAS
- ---------------------------------- ----------------------------------
Robert G. Jahn Lee M. Thomas


GAYNOR N. KELLEY
- ----------------------------------
Gaynor N. Kelley










41
43

EXHIBIT INDEX



Number Description Incorporated by Reference to

3-A Restated Certificate of Incorporation of Hercules Exhibit 3-A, Annual Report on Form 10-K,
Incorporated as revised and amended July 6, 1988. filed March 26, 1993.

3-B By-Laws of Hercules Incorporated as revised and Exhibit 3-B, Annual Report on Form 10-K,
amended October 30, 1991. filed March 26, 1993.

4-A Form of Rights Agreement between the company and Form 8-A filed July 10, 1987*.
Manufacturers Hanover Trust Company, dated as of
June 24,1987.

4-B The company is party to several long-term debt
instruments under which in each case the total amount
of securities authorized does not exceed 10% of the
total assets of Hercules. Pursuant to paragraph
4(iii)(A) of Item 601(b) of Regulation S-K, the
company agrees to furnish a copy of such instruments
to the Securities and Exchange Commission upon
request.

10-A Hercules Incorporated Unit Incentive Plan. Appendix A, Notice of Annual Meeting and
Proxy Statement Dated February 10, 1969*.

10-B Hercules Executive Survivor Benefit Plan. Exhibit 10-D, Annual Report on Form
10-K, filed March 27, 1981*.

10-C Hercules Incorporated Phantom Stock Plan. Exhibit E, Notice of Annual Meeting and
Proxy Statement Dated February 14, 1986*.

10-D Hercules Incorporated Restricted Stock Plan of 1986. Exhibit B, Notice of Annual Meeting and
Proxy Statement Dated February 14, 1986*.

10-E Hercules Incorporated Stock Option Plan of 1986. Exhibit D, Notice of Annual Meeting and
Proxy Statement Dated February 14, 1986*.

10-F Hercules Incorporated Deferred Compensation Plan. Exhibit 10-I, Annual Report on Form 10-K,
filed March 29, 1988.

10-G Hercules Incorporated Long Term Incentive Exhibit 4.1, Registration Statement on
Compensation Plan. Form S-8, filed July 1, 1993.

10-H Hercules Incorporated Annual Management Incentive Exhibit 10-H, Annual Report on Form 10-K,
Compensation Plan. filed March 26, 1993.

10-I Hercules Incorporated 1993 Nonemployee Director Stock Exhibit 4.1, Registration Statement on
Accumulation Plan. Form S-8, filed July 16, 1993.






42
44
EXHIBIT INDEX (CONT'D)



Number Description Incorporated by Reference to

10-J Hercules Incorporated Deferred Compensation Plan Exhibit 10-J, Annual Report on Form 10-K,
for Nonemployee Directors. filed March 26, 1993.

10-K Hercules Incorporated Retirement Plan for Exhibit 10-K, Annual Report on Form 10-K,
Nonemployee Directors. filed March 26, 1993.

10-L Hercules Employee Pension Restoration Plan. Exhibit 10-L, Annual Report on Form 10-K,
filed March 26, 1993.

10-M Form of Employment Contract between the company and Exhibit 10-J, Annual Report on Form 10-K,
certain directors and officers of the company. filed March 29, 1988*.

10-N Form of Indemnification Agreement between the company Annex II, Notice of Annual Meeting and
and certain directors and officers of the company. Proxy Statement Dated February 19, 1987*.

10-P Hercules Incorporated Long Term Incentive Exhibit 10-P, Amended and restated as of
Compensation Plan April 27, 1995.

21 Subsidiaries of the Registrant. Page 38 of 1996 Form 10-K. See Part II,
Item 8.
23-A Consent of Independent Accountants. Page 44 of 1996 Form 10-K.

27 Financial Data Schedule




* Previously filed as indicated and incorporated herein by reference.
Exhibits incorporated by reference should be located in SEC File No.
1-496.















43